Skip to main content

Advertisement

Table 6 Repeated measures multivariate regression: effect of gender on EuroQol score

From: Gender differences in asthma perception and its impact on quality of life: a post hoc analysis of the PROXIMA (Patient Reported Outcomes and Xolair® In the Management of Asthma) study

  Estimate Standard Error p-value
Intercept 0.820 0.071 < 0.0001
Gender (females vs males) − 0.055 0.024 0.028
Visit (6-month follow up vs baseline) 0.093 0.015 < .0.0001
Visit (12-month follow up vs baseline) 0.099 0.015 < .0.0001
Age (years) 0.000 0.001 0.826
Comorbidities (no vs yes) 0.037 0.025 0.147
Smoke (current/former vs no smoker) − 0.009 0.028 0.752
Asthma duration (years) 0.000 0.001 0.712
ICS (no vs yes) − 0.026 0.029 0.382
ICS + LABA (no vs yes) − 0.032 0.041 0.439
OCS (no vs yes) 0.039 0.036 0.278
Omalizumab total dose (mg) 0.000 0.003 0.510
Exacerbations in the 12 months before enrollment (0 vs ≥ 1) 0.052 0.063 0.409